NCCN Continuing Education |

Title	Credit	Dates
NCCN Pharmacy Updates: The Evolving Landscape of Immunotherapy and Targeted Therapy for Non-Small Cell Lung Cancer	1.00 ACPE contact hours credit 1.00 AMA PRA Category 1 Credit™ credit 1.00 ANCC contact hours credit 1.00 Participation credit	08/27/2018 - 12:00pm to 1:00pm
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Breast Cancer	1.00 ACPE contact hours credit 1.00 AMA PRA Category 1 Credit™ credit 1.00 ANCC contact hours credit 1.00 CCM clock hours credit 1.00 Participation credit	08/28/2018 - 1:30pm to 2:30pm
NCCN 2018 Congress Webinar Series: Acute Leukemia - Monitoring Minimal Residual Disease in Leukemia and Impact on Treatment	1.00 ABIM MOC credit 1.00 ACPE contact hours credit 1.00 AMA PRA Category 1 Credit™ credit 1.00 ANCC contact hours credit 1.00 Participation credit	09/06/2018 - 1:00pm to 2:00pm
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Ovarian Cancer	1.00 ACPE contact hours credit 1.00 AMA PRA Category 1 Credit™ credit 1.00 ANCC contact hours credit 1.00 CCM clock hours credit 1.00 Participation credit	09/25/2018 - 10:30am to 11:30am
NCCN Pharmacy Updates: Introduction to the NCCN Guidelines® for Vulvar Cancer and Corresponding Systemic Therapy Recommendations	1.00 ACPE contact hours credit 1.00 AMA PRA Category 1 Credit™ credit 1.00 ANCC contact hours credit 1.00 Participation credit	09/27/2018 - 2:00pm to 3:00pm

Pages

Title	Credit	Type
Biosimilars in the Evolving Cancer Care Landscape: Experts Address Current Questions, Controversies, and Impact on Clinical Practice	1.00 ACPE contact hours credit 1.00 AMA PRA Category 1 Credit™ credit 0.88 ANCC contact hours credits 1.00 Participation credit	Enduring
Emerging Systemic Therapy Options in Advanced Hepatocellular Carcinoma	0.75 ACPE contact hours credits 0.75 AMA PRA Category 1 Credit™ credits 0.82 ANCC contact hours credits 0.75 Participation credits	Enduring
Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy	1.00 ACPE contact hours credit 1.00 AMA PRA Category 1 Credit™ credit 0.88 ANCC contact hours credits 1.00 Participation credit	Enduring
Emerging Strategies in the Upfront Treatment of Hodgkin Lymphoma	0.75 ACPE contact hours credits 0.75 AMA PRA Category 1 Credit™ credits 0.72 ANCC contact hours credits 0.75 Participation credits	Enduring
Recorded Presentation from the NCCN 2018 Nursing Program Webinar Series - Improving Quality of Care for Lesbian, Gay, Bisexual, and Transgender (LGBT...	0.85 ANCC contact hours credits 0.85 Participation credits	Enduring